The Impact of Pediatric Skin Disorders: The "Big" Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1666 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-16

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments

NCT03051347

Atopic Dermatitis Ichthyosis Psoriasis

COMPLETED NA

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)

NCT03849716

Dermatitis Atopic

ACTIVE_NOT_RECRUITING

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

NCT05042258

Atopic Dermatitis Sleep Disturbance

RECRUITING PHASE4

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

NCT01782703

Atopic Dermatitis Eczema

ACTIVE_NOT_RECRUITING

Effects of Treatments on Atopic Dermatitis

NCT01631617

Eczema Dermatitis Skin Diseases, Genetic +2 more

RECRUITING PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a multi center study with Northwestern University/Lurie Children's Hospital serving as the Data Coordinating Center. Site selection has been completed through members of PeDRA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pediatric Skin Conditions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must be aged 8-17 years of age
* Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
* Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
* Subject and Parent/Guardian must be able to complete the relevant questionnaires

Exclusion Criteria

* Children under 8 years of age
* Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
* Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing

Minimum Eligible Age

8 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No